Takeda CEO Weber to Retire in June 2026
Tokyo, Jan. 30 (Jiji Press)--Japan's Takeda Pharmaceutical Co. said Thursday that its president and CEO, Christophe Weber, will step down at its general shareholders meeting in June 2026. Julie Kim, 54, head of Takeda's U.S. operations, was named to succeed Weber. The planned change in leadership reflects Weber's long tenure as president and the fact that some management reforms carried o...
Tomas Kauer - News Moderator 
Tokyo, Jan. 30 (Jiji Press)--Japan's Takeda Pharmaceutical Co. said Thursday that its president and CEO, Christophe Weber, will step down at its general shareholders meeting in June 2026. Julie Kim, 54, head of Takeda's U.S. operations, was named to succeed Weber. The planned change in leadership reflects Weber's long tenure as president and the fact that some management reforms carried o...
